Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy.

ABSTRACT:

Background

Gastrointestinal stromal tumour (GIST) is the most common intra-abdominal sarcoma. Risk classification systems, commonly the modified National Institutes of Health consensus criteria, identify tumour properties relating to patient outcomes. However, owing to limited long-term evidence, most guidelines recommend up to 10-year follow-up for all risk groups except very low-risk GIST.

Methods

This retrospective multicentre study included patients who had complete resection of primary, non-metastatic GIST from three Scandinavian sarcoma centres: Gothenburg (2004-2020), Stockholm (2000-2019), and Oslo (2000-2017). Medical records were reviewed for clinical details regarding diagnosis, treatment, and follow-up, and recurrence-free and disease-specific survival evaluated.

SUBMITTER: Berndsen M 

PROVIDER: S-EPMC10638541 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature